Candela GentleMax Pro Plus
Alexandrite + Nd:YAG · Dual 755nm alexandrite + 1064nm Nd:YAG
Technology: Alexandrite Laser
Classification & configurations
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
At a glance
- New price
- $110k–$140kSource not documented
- FDA status
- Supplies & recurring costs
- Cooling supplies depend on configuration. DCD uses cryogen; ACC air cooling is optional.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers.
Read FDA-cleared indicationsExact wording from 3 FDA records
K201111 (Candela Corporation, 2020)
755nm: Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). 1064nm: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.)
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K112715 (Candela Corp., 2011)
GentleMAX Family of Laser Systems Division of Surgical, Orthopedic, and Restorative Devices 755nm 5l0(k)Number, K 11i-iis The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable longterm or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick [-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias) 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PEB. The lasers are indicated on all skin types Fitzpatrick I-yE including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but 'not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K133283 (Candela Corp., 2013)
The GentleMAX Family of Laser Systems is indicated for the following: 'lS5nm The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick I- VI) including tanned skin. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas. telangiectasias. GentleMAX Family of Laser Systems 7-1 A3 - I 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of P113. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick 1-VI including tanned skin. Photocoagulation and hemlostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangiorna, warts. telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au lait macules, seborrheic keratosis, nevi. chloasma. verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hyperirophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Description: The Candela GentleMAX Family of Laser Systems contains two separate laser heads (Alexandrite and Nd:YAG), wvhich produce laser light Outputs of 755 rn and 1064 rn, respectively.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 19, 2026 · How we verify
Axis runs $0–$140k. Reference figures, not current offers.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | Candela |
|---|---|
| Company | Owner: Apax Partners (funds advised by Apax) (private equity owned, since 2017) · Distribution: direct |
| Parent company | Candela Medical |
| Brand owner | Candela |
| Built by (OEM) | Candela Corporation |
| Category | Alexandrite + Nd:YAG |
| Technology | Dual 755nm alexandrite + 1064nm Nd:YAG |
| FDA status | FDA Cleared |
| 510(k) citation | K201111, K112715, K133283 |
| New price range | $110k–$140k |
| Used asking range | Not published |
| Consumables | Cooling supplies depend on configuration. DCD uses cryogen; ACC air cooling is optional. |
| Launch year | 2021 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Alternatives to compare: Cynosure Elite iQ, Lumenis Splendor X, Alma Soprano Titanium and Motus AZ+. Compare the intended treatments, included handpieces, cooling and service terms.
How it worksTechnology and manufacturing
How the technology works
Dual solid-state lasers: 755nm Alexandrite for Fitzpatrick I-III hair, pigment, and epidermal lesions; 1064nm Nd:YAG for IV-VI hair, leg veins, deeper vascular work, wrinkles, onychomycosis.
Melanin or hemoglobin absorbs the pulse and converts it to heat, destroying the target while cryogen spray protects the epidermis milliseconds beforehand. The Plus generation raised max energy and repetition and added spots up to 26mm — deeper effective penetration at speed.
Hair removal is the revenue core; vascular and pigment are the margin-expanding side menu.
Patented technology
DCD (Dynamic Cooling Device) — a metered cryogen burst sprayed milliseconds before each pulse; patented epidermal protection enabling higher fluences with less pain and fewer burns, and the main reason techs and patients are loyal to the Gentle line.
Origin
Marlborough, Massachusetts HQ with US manufacturing heritage for the Gentle line; current production siting varies — verify.
FDA & regulatory detailClearance timeline, authorization route and citation notes
FDA-cleared indications (verbatim)
K201111 (Candela Corporation, 2020)
755nm: Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). 1064nm: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.)
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K112715 (Candela Corp., 2011)
GentleMAX Family of Laser Systems Division of Surgical, Orthopedic, and Restorative Devices 755nm 5l0(k)Number, K 11i-iis The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable longterm or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick [-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias) 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PEB. The lasers are indicated on all skin types Fitzpatrick I-yE including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but 'not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K133283 (Candela Corp., 2013)
The GentleMAX Family of Laser Systems is indicated for the following: 'lS5nm The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick I- VI) including tanned skin. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas. telangiectasias. GentleMAX Family of Laser Systems 7-1 A3 - I 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of P113. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick 1-VI including tanned skin. Photocoagulation and hemlostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangiorna, warts. telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au lait macules, seborrheic keratosis, nevi. chloasma. verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hyperirophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Description: The Candela GentleMAX Family of Laser Systems contains two separate laser heads (Alexandrite and Nd:YAG), wvhich produce laser light Outputs of 755 rn and 1064 rn, respectively.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Alexandrite — Dual 755nm alexandrite + 1064nm Nd:YAG
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Candela Medical
Legal manufacturer: Candela Corporation (United States)
Applicant on the FDA record
Candela CorporationThe applicant named on the FDA record can differ from the brand shown on the device.
Clearance notes
K112715 / K133283 family; Pro Plus K201111 — permanent hair reduction, benign pigmented and vascular lesions, wrinkles, onychomycosis and soft-tissue coagulation.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
No model-specific profit-margin benchmark is documented here. Build your estimate from the price you expect to collect, treatment volume, staff time and equipment payments.
Include cooling supplies, replacement parts and service for your exact configuration. Ask the seller for those costs in writing.
Supplies & recurring costs
DCD cooling uses replacement cryogen containers. Candela also offers an optional Air Cooling Compatible (ACC) delivery system.
Ask for a supply and replacement-parts quote for your exact handpiece and cooling configuration. Per-treatment and annual supply costs have not been verified here.
Source notes
Candela GentleMax Pro Plus brochure PU07645EN Rev.102 (2024), technical specifications, page8; checked September19,2026. Supports cryogen-based DCD and optional ACC configurations, not a per-treatment or annual cost estimate.
Current product listing: https://candelamedical.com/products/gentle-pro-series/ . No price observation recorded.
Additional supply notes
Cooling supplies depend on configuration. DCD uses cryogen; ACC air cooling is optional.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published Candela GentleMax Pro Plus data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
ComplianceScreening and contraindications on the manufacturer's record
Contraindications & screening
Pregnancy, active or recent tan (defer Alexandrite; the 1064 gives an option), photosensitizing meds, recent isotretinoin, active infection/herpes, tattoos in the field, suspicious pigmented lesions. DCD reduces but does not eliminate burn risk from wrong-wavelength/fluence choices.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
Ideal Image
Aesthetic chain
2025 fleet upgrade to Pro Plus-class Candela
ConfirmedSEV Laser
Hair removal chain
Runs Candela alongside Cynosure Elite iQ
Reported- Confirmed
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
Research comparisons
Includes current and older models.
History6 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 19, 2026
Economics and overview evidence
Replaced unsupported treatment-price, margin or comparative assertions in economics and overview prose with neutral quote-planning guidance. No purchase prices, source records, review scores, model status or verification dates changed. Full earlier wording is retained in this database correction record; the public history shows this summary.
Source: Catalog update
September 19, 2026
Used price range
Used GentleMax Pro $35k–$65k → —
Source: Catalog update
September 19, 2026
Availability status
Current (GentleMax Pro discontinued, huge used market) → Current
Source: Catalog update
September 19, 2026
Model-specific pricing and supplies
Removed a used-price range explicitly naming GentleMax Pro from the Pro Plus record. Removed unsupported per-treatment/annual supply and service estimates and comparative language. Lifecycle label now refers only to Pro Plus. No finding about availability of older GentleMax Pro units is implied.
Source: https://marketing.candelamedical.com/rs/620-HCU-218/images/PU07645EN-Rev-102-GentleMaxPro-Plus-GLX%20Product%20Brochure%20LR_EN.pdf?version=0
September 7, 2026
notes
Source: Catalog update — editorial sentences removed (neutral-voice standard, 7 Sep 2026)
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Candela GentleMax Pro Plus — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.